GN

Greg Norden

Director at Royalty Pharma

Greg Norden is the former Chief Financial Officer of Wyeth. Mr. Norden also serves on the Boards of Zoetis, the leading animal health company; NanoString, a leading provider of life science tools for translational medicine; and Praxis, a clinical-stage biopharmaceutical company. Mr. Norden is a former director of Human Genome Sciences, Univision, and Welch Allyn. In addition, Mr. Norden is the Managing Director of G9 Capital Group, LLC, which invests in early-stage ventures and provides corporate advisory services. Mr. Norden has a B.S. in Management and Economics from the State University of New York at Plattsburgh and an M.S. in Accounting from LIU Post.

Timeline

  • Director

    Current role